• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Eliquis (apixaban) 2.5 and 5 mg Tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

 

January 2014

Summary View

8 USE IN SPECIFIC POPULATIONS

8.6 End-Stage Renal Disease Patients Maintained with Hemodialysis
  • new subsection added


note: also changes to DOSAGE AND ADMINISTRATION, 2.7 Renal Impairment